nach oben

The journal of nutrition, health & aging

Erschienen in:

22.02.2018 | Editorial

Orthogeriatrics and Hip Fractures

verfasst von: A. M. Sanford, John E. Morley, A. McKee

Erschienen in: The journal of nutrition, health & aging | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Excerpt

Approximately 14% of women and 6% of men will have a hip fracture during their life time (1). There is large geographical variation in hip fractures with the highest rates occurring in Scandinavian countries (over 500/100,000 annual age-standardized incidence) and the lowest rates in African countries (less than 100/100,000 age-standardized incidence) (2). In the United States, rates of hip fracture vary between 143 to 316/100,000 for Caucasians and 76 to 136/100,000 for persons of African origin. …

Lauritzen JB. Hip fractures. Epidemiology, risk factors, falls, energy absorption, hip protectors and prevention. Dan Med Bull 1997;44:155–168.PubMed

Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C; IOF Working Group on Epidemiology and Quality of Life. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporosis Int 2012;23:2239–2256.CrossRef

Bhandari M, Swiontkowski M. Management of acute hip fracture. N Engl J Med 2017;377:2053–2062.PubMedCrossRef

Devas MB. Geriatric Orthopaedics. Br Med J 1974;1(5900):190–192.PubMedPubMedCentralCrossRef

Lefroy RB. Treatment of patients with fractured neck of the femur in a combined unit. Med J Aust 1980;2:669–670.PubMed

Adunsky A, Lerner-Geva L, Blumstein T, Boyko V, Mizrahi E, Arad M. Improved survival of hip fracture patients treated within a comprehensive geriatric hip fracture unit, compared with standard of care treatment. J Am Med Dir Assoc 2011;12:439–444.PubMedCrossRef

Prestmo A, Hagen G, Sletvold O, et al. Comprehensive geriatric care for patients with hip fractures: A prospective, randomised, controlled trial. Lancet 2015;385:1623–1633.PubMedCrossRef

Grigoryan KV, Javedan H, Rudolph JL. Orthogeriatric care models and outcomes in hip fracture patients: A systematic review and meta-analysis. J Orthop Trauma 2014;28:e49–e55.PubMedPubMedCentralCrossRef

Heyes GJ, Tucker A, Marley D, Foster A. Predictors for 1-year mortality following hip fracture: A retrospective review of 465 consecutive patients. Eur J Trauma Emerg Surg 2017;43:113–119.PubMedCrossRef

10.

Cram P, Yan L, Bohm E, Kuzyk P, Lix LM, Morin SN, Majumdar SR, Leslie WD. Trends in operative and nonoperative hip fracture management 1990-2014: A longitudinal analysis of Manitoba administrative data. J Am Geriatr Soc 2017;65:27–34.PubMedCrossRef

11.

Kamel HK, Iqbal MA, Mogallapu R, Maas D, Hoffmann RG. Time to ambulation after hip fracture surgery: Relation to hospitalization outcomes. J Gerontol A Biol Sci Med Sci 2003;58:1042–1045.PubMedCrossRef

12.

Malik AT, Panni UY, Masri BA, Noordin S. The impact of surgeon volume and hospital volume on postoperative mortality and morbidity after hip fractures: A systematic review. Int J Surg 2017;Nov 2. Doi: 10.1016.j.ijsu.2017.10.072 [Epub ahead of print].

13.

Moja L, Piatti A, Pecoraro V, Ricci C, Virgili G, Salanti G, et al. Timing matters in hip fracture surgery: Patients operated within 48 hours have better outcomes. A metaanalysis and meta-regression of over 190,000 patients. PLoS One 2012;7(10):e46175.PubMedPubMedCentralCrossRef

14.

Keil DS, Gross S, Seymour RB, Sims S, Karunakar MA. Mortality after high energy pelvic fractures in patients of age 65 or older. J Orthop Trauma 2017; Sep 29. Doi: 10.1097/BOT.0000000000001041 [Epub ahead of print].

15.

Rai SK, Varma R, Wani SS. Does time of surgery and complication have any correlation in the management of hip fracture in elderly and can early surgery affect the outcome? Eur J Orthop Surg Traumatol 2017; Oct 7. Doi: 10.1007/s00590-017-2047-0. [Epub ahead of print].

16.

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453–2462.PubMedPubMedCentralCrossRef

17.

Gregersen M, Borris LC, Damsgaard EM. Blood transfusion and overall quality of life after hip fracture in frail elderly patients—the transfusion requirements in frail elderly randomized controlled trial. J Am Med Dir Assoc 2015;16:762–766.PubMedCrossRef

18.

Morrison RS, Dickman E, Hwang U, Akhtar S, Ferguson T, Huang J, et al. Regional nerve blocks improve pain and functional outcomes in hip fracture: A randomized controlled trial. J Am Geriatr Soc 2016;64:2433–2439.PubMedPubMedCentralCrossRef

19.

Guay J, Parker MJ, Griffiths R, Kopp SL. Peripheral nerve blocks for hip fractures: A Cochrane review. Anesth Analg 2017;Oct 4. Doi: 10.1213/ANE.0000000000002489 [Epub ahead of print].

20.

Kabboord AD, van Eijk M, Fiocco M, van Balen R, Achterberg WP. Assessment of comorbidity burden and its association with functional rehabilitation outcome after stroke or hip fracture: A systematic review and meta-analysis. J Am Med Dir Assoc 2016;17:1066.e13–1066.e21.CrossRef

21.

Chen KW, Chang SF, Lin PL. Frailty as a predictor of future fracture in older adults: A systematic review and meta-analysis. Worldviews Evid Based Nurs 2017;14:282–293.PubMedCrossRef

22.

Zaslavsky O, Zelber-Sagi S, Gray SL, LaCroix AZ, Brunner RL, Wallace RB, et al. Comparison of frailty phenotypes for prediction of mortality, incident falls, and hip fracture in older women. J Am Geriatr Soc 2016;64:1858–1862.PubMedPubMedCentralCrossRef

23.

Malmstrom TK, Miller DK, Morley JE. A comparison of four frailty models. J Am Geriatr Soc 2014;62:721–726.PubMedPubMedCentralCrossRef

24.

Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013;14:392–297.PubMedPubMedCentralCrossRef

25.

Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012;16:601–608.PubMedPubMedCentralCrossRef

26.

Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012;60:1478–1486.PubMedCrossRef

27.

Dent E, Lien C, Lim WS, Wong WC, Wong Ch, Ng TP, Woo J, et al. The Asia-Pacific clinical practice guidelines for the management of frailty. J Am Med Dir Assoc 2017;18:564–575.PubMedCrossRef

28.

Gleason LJ, Benton EA, Alvarez-Nebreda ML, Weaver MJ, Harris MB, Javedan H. FRAIL questionnaire screening tool and short-term outcomes in geriatric fracture patients. J Am Med Dir Assoc 2017;Aug 30. Doi: 10.1016/j.jamda.2017.07.005 [Epub ahead of print].

29.

Morley JE. Developing novel therapeutic approaches to frailty. Curr Pharm Design 2009;15:3384–3395.CrossRef

30.

McKee A, Morley JE, Matsumoto AM, Vinik A. Sarcopenia: An endocrine disorder? Endocr Pract 2017;23:1140–1149.PubMedCrossRef

31.

Yadigar S, Yavuzer H, Yavuzer S, Cengiz M, Huruyen M, Doventas A, Eerdincler DS. Primary sarcopenia in older people with normal nutrition. J Nutr Health Aging 2016;20:234–238.PubMedCrossRef

32.

Cederholm T, Morley JE. Sarcopenia: The new definitions. Curr Opin Clin Nutr Metab Care 2015;18:1–4.PubMedCrossRef

33.

Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 2011;12:403–409.PubMedPubMedCentralCrossRef

34.

Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011;12:249–256.PubMedCrossRef

35.

Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: Facts, numbers, and epidemiology-update 2014. Sarcopenia Muscle 2015;6:192.CrossRef

36.

Chen LK, Lee WJ, Peng LN, Liu LK, Arai H, Akishita M; Asian Working Group for Sarcopenia. Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2016;17:767.e1–7.CrossRef

37.

Kim S, Kim M, Won CW. Validation of the Korean Version of the SARC-F questionnaire to assess sarcopenia: Korean frailty and aging cohort study. J Am Med Dir Assoc 2017; doi: 10.1016/j.jamda.2017.07.006.

38.

Tanaka S, Kamiya K, Hamazaki N, Matsuzawa R, Nozaki K, Maekawa E, et al. Utility of SARC-F for assessing physical function in elderly patients with cardiovascular disease. J Am Med Dir Assoc 2017;18:176–181.PubMedCrossRef

39.

Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 2016;7:28–36.PubMedCrossRef

40.

Morley JE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 2016;98:319–333.PubMedCrossRef

41.

Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an International classification of disease, Tenth Revision, Clinical Modivication (ICD-10-CM) code. J Am Med Dir Assoc 2016;17:675–677.PubMedCrossRef

42.

Anker DS, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 2016;7:512–514.PubMedPubMedCentralCrossRef

43.

Harris R, Chang Y, Beavers K, Laddu-Patel D, Bea J, Johnson K, et al. Risk of fracture in women with sarcopenia, low bone mass, or both. J Am Geratr Soc 2017; Sep 27. Doi: 10.111/jgs.15050 [Epub ahead of print].

44.

Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Gunawardene P, et al. Comprehensive nutritional status in sarco-osteoporotic older fallers. J Nutr Health Aging 2015;19:474–480.PubMedCrossRef

45.

Morley JE. Hip fractures. J Am Med Dir Assoc 2010;11:81–83.PubMedCrossRef

46.

Chan DC, Chang CB, Han DS, Hong CH, Hwang JS, Tsai KS, Yang RS. Effects of exercise improves muscle strength and fat mass in patients with high fracture risk: A randomized control trial. J Formos Med Assoc 2017; Oct 26 doi: 10.1016/j. jfma.2017.05.004 [Epub ahead of print].

47.

Morley JE. Osteoporosis and fragility fractures. J Am Med Dir Assoc 2011;12:389–392.PubMedCrossRef

48.

Liccini A, Malmstrom TK. Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc 2016;17:846–851.PubMedCrossRef

49.

Morley JE, Malmstrom TK, Rodriguez-Manas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc 2014;15:853–859.PubMedCrossRef

50.

Morley JE. Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 2007;13:3637–3647.PubMedCrossRef

51.

Kellett J, Kyle G, Istiopoulos C, Naunton M. Nutrition screening practice amongst Australian residential aged care facilities. J Nutr Health Aging 2016;20:1040–1044.PubMedCrossRef

52.

Vellas B, Villars H, Abellan G, Soto ME, Rolland Y, Guigoz Y, et al. Overview of the MNA—its history and challenges. J Nutr Health Aging 2006;10:456–463.PubMed

53.

van Wissen J, van Stijn MF, Doodeman HJ, Houdijk AP. Mini nutritional assessment and mortality after hip fracture surgery in the elderly. J Nutr Health Aging 2016;20:964–968.PubMedCrossRef

54.

Goisser S, Schrader E, Singler K, Bertsch T, Gefeller O, Biber R, Bail HJ, et al. Malnutrition according to mini nutritional assessment is associated with severe functional impairment in geriatric patients before and up to 6 months after hip fracture. J Am Med Dir Assoc 2015;16:661–667.PubMedCrossRef

55.

van Wissen J, van Stijn MF, Doodeman HJ, Joudijk AP. Mini nutritional assessment and mortality after hip fracture surgery in the elderly. J Nutr Health Aging 2016;20:964–968.PubMedCrossRef

56.

Reider L, Hawkes W, Hebel JR, D’Adamo C, Magaziner J, Miller R, et al. The association between body mass index, weight loss and physical function in the year following a hip fracture. J Nutr Health Aging 2013;17:91–95.PubMedPubMedCentralCrossRef

57.

Landi F, Picca A, Clavani R, Marzetti E. Anorexia of Aging: Assessment and Management. Clin Geriatr Med 2017;33:315–323.PubMedCrossRef

58.

Morley JE. Anorexia of ageing: A key component in the pathogenesis of both sarcopenia and cachexia. J Cachexia Sarcopenia Muscle. 2017;8:523–526.PubMedPubMedCentralCrossRef

59.

Sanford AM. Anorexia of aging and its role for frailty. Curr Opin Clin Nutr Metab Care 2017;20:54–60.PubMedCrossRef

60.

Morley JE. Anorexia of aging: A true geriatric syndrome. J Nutr Health Aging 2012;16:422–425.PubMedCrossRef

61.

Pilgrim AL, Baylis D, Jameson KA, Cooper C, Sayer AA, Robinson SM, Roberts HC. Measuring appetite with the Simplified Nutritional Appetite questionnaire identifies hospitalised older people at risk of worse health outcomes. J Nutr Health Aging 2016;20:3–7.PubMedPubMedCentralCrossRef

62.

Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, Diebold MR, Morley JE. Appetite assessment: Simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005;82:1074–1081.PubMedCrossRef

63.

Brauer C, Morrison RS, Silberzweig SB, et al. The cause of delirium in patients with hip fracture. Arch Intern Med 2000;160:1856–1860.PubMedCrossRef

64.

Marcantonio ER, Vlacker JM, Michaels M, et al. Delrium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc 2000;48:618–624.PubMedCrossRef

65.

Lundstrom M, Olofsson B, Stenvall M, et al. Postoperative delirium in old patients with demoral neck fracture: A randomized intervention study. Aging Clin Exp Res 2007;19:178–186.PubMedCrossRef

66.

Flaherty JH, Morley JE. Delirium in the nursing home. J Am Med Dir Assoc 2013;14:632–634.PubMedCrossRef

67.

Scholtens RM, van Munster BC, Adamis D, de Jonghe A, Meagher DJ, de Rooij SE. Variability of delirium motor subtype scale-defined delirium motor subty0pes in elderly adults with hip fracture: A longitudinal study. J Am Geriatr Soc 2017;65:e45–e50.PubMedCrossRef

68.

Mitchell R, Harvey L, Brodaty H, Draper B, Close J. One-year mortality after hip fracture in older individuals: The effects of delirium and dementia. Arch Gerontol Geriatr 2017;72:135–141.PubMedCrossRef

69.

Witlox J, Eurelings LSM, de Jonghe JFM, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization,a nd dementia: A meta-analysis. JAMA 2010;304:443–451.PubMedCrossRef

70.

Mangoni AA, van Munster BC, Woodman RJ, de Roij SE. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry 2013;21:785–793.PubMedCrossRef

71.

Mazzola P, Ward L, Zazzetta S, Broggini V, Anzuini A, Valcarcel B, et al. Association between preoperative malnutrition and postoperative delirium after hip fracture surgery in older adults. J Am Geriatr Soc 2017;65:1222–1228.PubMedCrossRef

72.

Iaboni A, Rawson K, Burkett C, Lenze EJ, Flint AJ. Potentially inappropriate medications and the time to full functional recovery after hip fracture. Drugs Aging 2017;34:723–728.PubMedCrossRefPubMedCentral

73.

Neerland BE, Hall RJ, Seljeflot I, Frihagen F, MacLullich AM, Raeder J, et al. Associations between delirium and preoperative cerebrospinal fluid C-reactive protein, Interleukin-6, and Interleukin-6 receptor in individuals with acute hip fracture. J Am Geriatr Soc 2016;64:1456–1463.PubMedCrossRef

74.

Wang Y, Tang J, Zhou F, Yang L, Wu J. Comprehensive geriatric care reduces acute perioperative delirium in elderly patients with hip fractures: A meta-analysis. Medicine (Baltimore). 2017;96:e7361.PubMedPubMedCentralCrossRef

75.

76.

Flaherty JH, Gonzales JP, Dong B. Antipsychotics in the treatment of delirium in older hospitalized adults: A systematic review. J Am Geriatr Soc 2011;59(Suppl 2):S269–S276.PubMedCrossRef

77.

Dovjak P, Iglseder B, Mikosch P, Gosch M, Muller E, Pinter G, et al. Treatment and prevention of postoperative complications in hip fracture patients: Infections and delirium. Wien Med Wochenschr 2013;163:448–454.PubMedCrossRef

78.

Johansson I, Athlin E, Frykholm L, Bolinder H, Larsson G. Intermittent versus indwelling catheters for older patients with hip fractures. J Clin Nurs 2002;11:651–656.PubMedCrossRef

79.

Neumaier M, Metak G, Scherer MA. C-reactive protein as a parameter of surgical trauma: CRP response after different types of surgery in 349 hip fractures. Acta Orthop. 2006;77:788–790.PubMedCrossRef

80.

Aarden JJ, van der Esch M, Engelbert RHH, van der Schaaf M, de Rooij SE, Buurman BM. Hip fractures in older patients: Trajectories of disability after surgery. J Nutr Health Aging 2017;21:837–842.PubMedCrossRef

81.

Diong J, Allen N, Sherrington C. Structured exercise improves mobility after hip fracture: A meta-analysis with meta-regression. Br J Sports Med 2016;50:346–355.PubMedCrossRef

82.

Fiatarone Singh NA, Quine S, Clemson LM, Williams EJ, Williamson DA, Stavrinos TM, Grady JN, et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 2012;13:24–30.CrossRef

83.

Kronborg L, Bandholm T, Palm H, Kehlet H, Kristensen MT. Effectiveness of acute in-hospital physiotherapy with knee-extension strength training in reducing strength deficits in patients with a hip fracture: A randomised controlled trial. PLoS One 2017;12:e0179867.PubMedPubMedCentralCrossRef

84.

Overgaard J, Kristensen MT. Feasibility of progressive strength training shortly after hip fracture surgery. World J Orthop 2013;4:248–258.PubMedPubMedCentralCrossRef

85.

Sylliaas H, Brovold T, Wyller TB, Bergland A. Prolonged strength training in older patients after hip fracture: A randomised controlled trial. Age Ageing 2012;41:206–212.PubMedCrossRef

86.

Laiz A, Malouf J, Marin A, Longobardi V, de Caso J, Farrerons J, Casademont J. Impact of 3-monthly vitamin D supplementation plus exercise on survival after surgery for osteoporotic hip fracture in adults patients over 50 years: A pragmatic randomized, partially blinded, controlled trial. J Nutr Health Aging 2017;21:413–420.PubMedCrossRef

87.

Singh NA, Quine S, Clemson LM, Williams EJ, Williamson DA, Stavrinos TM, et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 2012;13:24–30.PubMedCrossRef

88.

Lee SY, Yoon BH, Beom J, Ha YC, Lim JY. Effect of lower-limb progressive resistance exercise after hip fracture surgery: A systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc 2017;Oct 12 doi: 10.1016/j.jamda.2017.08.021 [Epub ahead of print].

89.

Karlsson A, Berggren M, Gustafson Y, Olofsson B, Lindelof N, Stenvall M. Effects of geriatric interdisciplinary home rehabilitation on walking ability and length of hospital stay after hip fracture: A randomized controlled trial. J Am Med Dir Assoc 2016;17:464.e9–464.e15.CrossRef

90.

Malafarina V, Uriz-Otano F, Malafarina C, Martinez JA, Zulet MA. Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients. A multi-centre randomized trial. Maturitas 2017;101:42–50.PubMed

91.

Avenell A, Smith TO, Curtain JP, Mak JC, Myint PK. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev 2016;11:CD001880.PubMed

92.

Seitz DP, Adunuri N, Gill SS, Rochon PA. Prevalence of dementia and cognitive impairment among older adults with hip fractures. J Am Med Dir Assoc 2011;12:556–564.PubMedCrossRef

93.

Gruber-Baldini AL, Hosseini M, Orwig D, Grattan L, Chiles Shaffer N, Hochberg M, Magaziner J. Cognitive differences between men and women who fracture their hip and impact on six-month survival. J Am Geriatr Soc 2017;65:e64–e69.PubMedPubMedCentralCrossRef

94.

Hall AJ, Lang IA, Endacott R, Hall A, Goodwin VA. Physiotherapy interventions for people with dementia and a hip fracture—a scoping review of the literature. Physiotherapy 2017;103:361–368.PubMedCrossRef

95.

Morley JE. New horizons in the management of Alzheimer disease. J Am Med Dir Assoc 2015;16:1–5.PubMedCrossRef

96.

Morley JE, Morris JC, Berg-Weger M, Borson S, Carpenter BD, Del Campo N, et al. Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc 2015;16:731–739.PubMedPubMedCentralCrossRef

97.

Berg-Weger M, Tebb S, Henderson-Kalb J, Zubatsky M, Lundy J, Hayden D. Cognitive stimulation therapy: A tool for your practice with persons with dementia? J Am Med Dir Assoc 2015;16:795–796.PubMedCrossRef

98.

Morley JE, Cruz-Oliver DM. Cognitive stimulation therapy. J Am Med Dir Assoc 2014;15:689–691.PubMedCrossRef

99.

Malmstrom TK, Voss VB, Cruz-Oliver DM, Cummings-Vaughn LA, Tumosa N, Grossberg GT, Morley JE. The Rapid Cognitive Screen (RCS): A point-ofcare screening for dementia and mild cognitive impairment. J Nutr Health Aging 2015;19:741–744.PubMedCrossRef

100.

Tariq SH, Tumosa N, Chibnall JT, Perry MH, Morley JE. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder—a pilot study. Am J Geriatr Psychiatry 2006;14:900–910.PubMedCrossRef

101.

Shaik MA, Chan QL, Xu J, Xu X, Hui RJ, Chong SS, Chen CL, Dong Y. Risk factors of cognitive impairment and brief cognitive tests to predict cognitive performance determined by a formal neuropsychological evaluation of primary health care patients. J Am Med Dir Assoc 2016;17:343–347.PubMedCrossRef

102.

Blain H, Masud T, Dargent-Molina P, martin FC, Rosendahl E, van der Velde N, et al. A comprehensive fracture prevention strategy in older adults: The European Union Geriatric Medicine Society (EUGMS) statement. J Nutr Health Aging 2016;20:647–652.PubMedPubMedCentralCrossRef

103.

Morley JE. Frailty, falls, and fractures. J Am Med Dir Assoc 2013;14:149–151.PubMedCrossRef

104.

Morley JE. Syncope. J Am Med Dir Assoc 2013;14:311–312.PubMedCrossRef

105.

Trahair LG, Horowitz M, Jones KL. Postprandial hypotension: A systematic review. J Am Med Dir Assoc 2014;15:394–409.PubMedCrossRef

106.

Vinik AI, Camacho P, Reddy S, Valencia WM, Trence D, Matsumoto AM, Morley JE. Aging, diabetes, and falls. Endocr Pract 2017;23:1117–1139.PubMed

107.

Morley JE. Syncope. J Am Med Dir Assoc 2013;14:311–312.PubMedCrossRef

108.

Tricco AC, Thomas SM, Veroniki AA, Hamid JS, Cogo E, Strifler L, et al. Comparisons for interventions for preventing falls in older adults: A systematic review and meta-analysis. JAMA 2017;318:1687–1699.PubMedCrossRefPubMedCentral

109.

Rolland Y, Morley JE. Frailty and polypharmacy. J Nutr Health Aging 2016;20:645–646.PubMedCrossRef

110.

Bakken MS, Schjott J, Engeland A, Engesaeter LB, Ruths S. Antipsychotic drugs and risk of hip fracture in people aged 60 and older in Norway. J Am Geriatr Soc 2016;64:1203–1209.PubMedCrossRef

111.

Hung SC, Lin CH, Hung HC, Lin CL, Lai SW. Use of selective serotonin reuptake inhibitors and risk of hip fracture in the elderly: A case-control study in Taiwan. J Am Med Dir Assoc 2017;18:350–354.PubMedCrossRef

112.

Bonjour JP, Benoit V, Atkin S, Walrand S. Fortification of yogurts with vitamin D and calcium enhances the inhibition of serum parathyroid hormone and bone resorption markers: A double blind randomized controlled trial in women over 60 living in a community dwelling home. J Nutr Health Aging 2015;19:563–569.PubMedPubMedCentralCrossRef

113.

Michaelsson K, Melhus H, Warensjo Lemming E, Wolk A, Byberg L. Long term calcium intake and rates of all cause and cardiovascular mortality: Community based prospective longitudinal cohort study. BMJ 2013;246:f228. Doi: 10.1136/bmj.f228.CrossRef

114.

Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991–2000.PubMedPubMedCentralCrossRef

115.

Nordstrom P, Toots A, Gustafson Y, Thorngren KG, Hommel A, Nordstrom A. Bisphosphonate use after hip fracture in older adults: A nationwide retrospective cohort study. J Am Med Dir Assoc 2017;18:515–521.PubMedCrossRef

116.

Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 2016;375:1532–1543.PubMedCrossRef

117.

Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med 2017;377:1417–1427.PubMedCrossRef

Titel: Orthogeriatrics and Hip Fractures
verfasst von: A. M. Sanford
John E. Morley
A. McKee
Publikationsdatum: 22.02.2018
Verlag: Springer Paris
Erschienen in: The journal of nutrition, health & aging / Ausgabe 4/2018
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI: https://doi.org/10.1007/s12603-018-1007-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Orthogeriatrics and Hip Fractures

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Muscle weakness and physical disability in older Americans: Longitudinal findings from the U.S. Health and Retirement Study

Smoking predicting physical activity in an aging America

Association between serum uric acid level and carotid atherosclerosis in Chinese individuals aged 75 years or older: A hospital-based case-control study

Dietary restriction ameliorates age-related increase in DNA damage, senescence and inflammation in mouse adipose tissuey

“Feeling more self-confident, cheerful and safe”. Experiences from a health-promoting intervention in community dwelling older adults — A qualitative study

Intake of 25-hydroxyvitamin D3 reduces duration and severity of upper respiratory tract infection: A randomized, double-blind, placebo-controlled, parallel group comparison study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin